Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocyte Transfusion | 2 | 2025 | 130 | 1.550 |
Why?
|
| Anemia, Sickle Cell | 3 | 2025 | 331 | 1.350 |
Why?
|
| Hemolysis | 1 | 2025 | 112 | 0.930 |
Why?
|
| ADAMTS13 Protein | 2 | 2024 | 63 | 0.900 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2024 | 53 | 0.860 |
Why?
|
| Thrombophilia | 1 | 2020 | 44 | 0.690 |
Why?
|
| Cyclin B | 1 | 2019 | 22 | 0.660 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2019 | 20 | 0.660 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 264 | 0.630 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 216 | 0.620 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 214 | 0.570 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2017 | 11 | 0.570 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2022 | 543 | 0.560 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2017 | 50 | 0.550 |
Why?
|
| Ascites | 1 | 2017 | 88 | 0.550 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 561 | 0.520 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 440 | 0.480 |
Why?
|
| Repressor Proteins | 1 | 2019 | 824 | 0.470 |
Why?
|
| ADAM Proteins | 2 | 2024 | 79 | 0.300 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3080 | 0.240 |
Why?
|
| Transfusion Reaction | 1 | 2025 | 42 | 0.240 |
Why?
|
| Microarray Analysis | 1 | 2024 | 238 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2023 | 360 | 0.210 |
Why?
|
| von Willebrand Factor | 2 | 2019 | 197 | 0.210 |
Why?
|
| Anticoagulants | 3 | 2024 | 594 | 0.200 |
Why?
|
| Gene Duplication | 1 | 2024 | 363 | 0.200 |
Why?
|
| Syndrome | 1 | 2025 | 1121 | 0.190 |
Why?
|
| Warfarin | 1 | 2023 | 119 | 0.190 |
Why?
|
| Acute Chest Syndrome | 1 | 2021 | 10 | 0.190 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2021 | 28 | 0.190 |
Why?
|
| Interferon Type I | 1 | 2022 | 107 | 0.190 |
Why?
|
| Exons | 1 | 2024 | 801 | 0.190 |
Why?
|
| Thrombosis | 2 | 2024 | 526 | 0.170 |
Why?
|
| Hemorrhage | 1 | 2023 | 470 | 0.160 |
Why?
|
| Humans | 11 | 2025 | 125757 | 0.160 |
Why?
|
| Casein Kinase I | 1 | 2019 | 12 | 0.160 |
Why?
|
| Platelet Adhesiveness | 1 | 2019 | 40 | 0.160 |
Why?
|
| Nephrectomy | 1 | 2019 | 179 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 157 | 0.150 |
Why?
|
| Microbiota | 1 | 2022 | 388 | 0.140 |
Why?
|
| Blood Platelets | 2 | 2009 | 327 | 0.130 |
Why?
|
| Protein Phosphatase 1 | 2 | 2023 | 51 | 0.130 |
Why?
|
| Male | 5 | 2024 | 61813 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1249 | 0.130 |
Why?
|
| Apoptosis | 1 | 2023 | 1818 | 0.130 |
Why?
|
| Stroke | 2 | 2021 | 990 | 0.120 |
Why?
|
| Female | 4 | 2024 | 67035 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1257 | 0.100 |
Why?
|
| Catalytic Domain | 2 | 2009 | 159 | 0.100 |
Why?
|
| Mice | 5 | 2023 | 17758 | 0.100 |
Why?
|
| Child | 3 | 2023 | 24605 | 0.100 |
Why?
|
| Prognosis | 1 | 2019 | 4700 | 0.090 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2009 | 62 | 0.080 |
Why?
|
| Thrombin | 1 | 2009 | 61 | 0.080 |
Why?
|
| Hemoglobin A | 1 | 2009 | 22 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2025 | 12425 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2434 | 0.080 |
Why?
|
| Pregnancy | 1 | 2021 | 7222 | 0.080 |
Why?
|
| Complement C3 | 1 | 2009 | 48 | 0.080 |
Why?
|
| Animals | 5 | 2023 | 34392 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2023 | 1641 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2025 | 16434 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2021 | 14137 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2024 | 107 | 0.050 |
Why?
|
| Young Adult | 1 | 2017 | 9119 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2023 | 42 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2024 | 215 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2024 | 202 | 0.050 |
Why?
|
| Adolescent | 1 | 2019 | 19477 | 0.050 |
Why?
|
| Cell Survival | 1 | 2023 | 820 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2022 | 217 | 0.040 |
Why?
|
| Platelet Aggregation | 2 | 2009 | 121 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 319 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 236 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 335 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 398 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 983 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 738 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 1305 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1410 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2022 | 4600 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2715 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8258 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2009 | 12 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 41 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2009 | 20 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 58 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 64 | 0.020 |
Why?
|
| Enzyme Repression | 1 | 2009 | 4 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2009 | 8 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 232 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2009 | 156 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 161 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 12594 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2009 | 62 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 295 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2009 | 89 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 493 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2009 | 528 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 1758 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 3755 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 4422 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 4416 | 0.010 |
Why?
|